HuMAB companies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HuMAB companies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (748)	9/30/2005 12:54:37 AM
From: DewDiligence_on_SI	of 1022

You ought to tell Merck KGaA that they didn’t develop it. This is from their latest annual report: merck.de >> Matuzumab: Humanized antibody from Merck’s own research labs Matuzumab (EMD 72000) is also an EGFR-specific monoclonal antibody and was developed by Merck in Darmstadt. <<

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next